A final rule from the Centers for Medicare and Medicaid Services, published August 13, ends federal payment for gender-transition care for minors enrolled in Medicaid and the Children's Health Insurance Program. 'This final rule requires that a State Medicaid plan must provide that the Medicaid agency will not make payment under the plan for sex-rejecting procedures for children under 18,' the rule states [1]. The CHIP cutoff is set one year higher, at under 19 [1]. The rule takes effect October 13, 2026 [1].
'Sex-rejecting procedures' is the rule's own term. It defines them as covering 'the use of puberty-suppressing drugs to prevent the onset of puberty; cross-sex hormones to spur the secondary sex characteristics of the opposite sex; and surgeries including mastectomy and (in rare cases) vaginoplasty' [1].
The timing is not uniform across those categories. For patients already receiving cross-sex hormones, the rule provides a six-month tapering window before federal funding stops. For puberty blockers and for surgeries, there is no taper: the federal share ends on the effective date [1].
The rule rests its case on the state of the medical evidence. 'The evidence for benefit of pediatric medical transition is very uncertain, while the evidence for harm is less uncertain,' it argues [1]. That is the strongest version of the government's position, and it is worth stating plainly rather than around: the rule does not assert the care is always wrong, only that the federal government should not pay for it while the benefit is contested.
Set beside that rationale is who loses coverage and when. The rule reports that 'Approximately 17 State Medicaid programs cover one or more forms of sex-rejecting procedures for children' [1]. Those states may keep covering the care, but only with state-only dollars, outside the federal match. It also cites its own count of the affected population: 'between 2016 and 2020, nearly 3,700 children between the ages of 12 and 18 diagnosed with gender dysphoria underwent surgical procedures, including over 3,200 children who had breast or chest surgery' [1].
The rule is not a total bar on the care. It carves out exceptions for medically verifiable disorders of sexual development, for treating infections, injuries, diseases, or complications from a prior procedure, and for physical conditions that place a child in danger of death or bodily-function impairment [1]. What it removes is the federal dollars, which for a low-income teenager already on blockers or scheduled for surgery is the difference between covered care on October 13 and none.
